As the updated COVID vaccines roll out around the country, one more competitor has joined the mix. In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it targets a SARS-CoV-2 variant, XBB.1.5, which is a descendant of Omicron.
Comments closedTag: Novavax
Topic: vaccinesView all posts for the topic: vaccines
EU delays approval of Novavax’s revised COVID vaccine
European Union (EU) regulators have delayed a decision to give approval for Novavax’s (NVAX.O) variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.
The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Novavax touts non-mRNA COVID-19 vaccine, hopeful to meet domestic production deadline
The last remaining manufacturer to offer an alternative to mRNA COVID-19 vaccines in Canada is hopeful it will meet the government’s 2024 deadline to make the shots domestically.
Comments closedTopic: NovavaxView all posts for the topic: Novavax
Novavax espère toujours fabriquer un vaccin contre la COVID-19 au Canada
The last manufacturer to offer an alternative to COVID-19 mRNA vaccines in Canada hopes to meet the government’s 2024 deadline for domestic dose production.
Novavax, based in Maryland, USA, held a press conference on Wednesday to tout the safety and efficacy of its new vaccine, which targets newer strains of COVID-19.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
FDA authorizes Novavax’s updated COVID vaccine for fall 2023
The Food and Drug Administration announced Tuesday it had authorized Novavax’s updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Updated Covid-19 vaccines are coming mid-September, officials say
Covid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, CDC and FDA officials said.
Comments closed